• EN
    • 1

    中国政府承诺将严厉打击医疗贿赂行为

    By | Published: 2013年8月13日
    GSK is currently under investigation in China for suspected bribery and tax-related offenses. China’s National Health and Family Planning Commission vowed to continue working with judicial agencies in efforts to curb commercial briber...